| scholarly article | Q13442814 |
| P50 | author | Petr Novak | Q58827926 |
| Fei Zhao | Q57038292 | ||
| P2093 | author name string | Walter T Klimecki | |
| Nathan J Cherrington | |||
| April D Lake | |||
| Rhiannon N Hardwick | |||
| Brieanna Flores-Keown | |||
| P2860 | cites work | pXBP1(U) encoded in XBP1 pre-mRNA negatively regulates unfolded protein response activator pXBP1(S) in mammalian ER stress response | Q24303865 |
| Unconventional splicing of XBP1 mRNA occurs in the cytoplasm during the mammalian unfolded protein response | Q24316572 | ||
| In vivo assessment of liver cell apoptosis as a novel biomarker of disease severity in nonalcoholic fatty liver disease | Q79788222 | ||
| ATF6 is a transcription factor specializing in the regulation of quality control proteins in the endoplasmic reticulum | Q80935578 | ||
| Hepatic cytochrome P450 enzyme alterations in humans with progressive stages of nonalcoholic fatty liver disease | Q24319917 | ||
| GAGE: generally applicable gene set enrichment for pathway analysis | Q24645628 | ||
| Regulation of hepatic lipogenesis by the transcription factor XBP1 | Q28507784 | ||
| The regulatory subunits of PI3K, p85alpha and p85beta, interact with XBP-1 and increase its nuclear translocation | Q28510062 | ||
| Characterization of stanniocalcin 2, a novel target of the mammalian unfolded protein response with cytoprotective properties | Q28578322 | ||
| XBP1 controls diverse cell type- and condition-specific transcriptional regulatory networks | Q28591575 | ||
| Autophagy regulates lipid metabolism | Q29547421 | ||
| Steatohepatitis: a tale of two "hits"? | Q29547771 | ||
| Design and validation of a histological scoring system for nonalcoholic fatty liver disease | Q29614930 | ||
| Constitutive role for IRE1α-XBP1 signaling pathway in the insulin-mediated hepatic lipogenic program | Q30426645 | ||
| Stanniocalcin 2 alters PERK signalling and reduces cellular injury during cerulein induced pancreatitis in mice | Q33890582 | ||
| Differing endoplasmic reticulum stress response to excess lipogenesis versus lipid oversupply in relation to hepatic steatosis and insulin resistance. | Q34166238 | ||
| Intracellular signaling from the endoplasmic reticulum to the nucleus: the unfolded protein response in yeast and mammals | Q34245400 | ||
| Diversity in antioxidant response enzymes in progressive stages of human nonalcoholic fatty liver disease | Q34359482 | ||
| Intersection of the unfolded protein response and hepatic lipid metabolism | Q34985745 | ||
| Autophagy in nonalcoholic steatohepatitis | Q35014344 | ||
| Endoplasmic reticulum stress and the unfolded protein response in nonalcoholic fatty liver disease | Q35055531 | ||
| Analysis of global and absorption, distribution, metabolism, and elimination gene expression in the progressive stages of human nonalcoholic fatty liver disease. | Q35264808 | ||
| Differential roles of unsaturated and saturated fatty acids on autophagy and apoptosis in hepatocytes | Q35429910 | ||
| Dysregulation of the unfolded protein response in db/db mice with diet-induced steatohepatitis | Q35490178 | ||
| Variations in ATP-binding cassette transporter regulation during the progression of human nonalcoholic fatty liver disease | Q35579538 | ||
| Pathophysiology of nonalcoholic steatohepatitis | Q36422705 | ||
| Apoptosis and autophagy: regulatory connections between two supposedly different processes | Q36996255 | ||
| ATF6 modulates SREBP2-mediated lipogenesis. | Q37260315 | ||
| Molecular mechanisms of lipotoxicity in nonalcoholic fatty liver disease | Q37310283 | ||
| Molecular mechanisms and the role of saturated fatty acids in the progression of non-alcoholic fatty liver disease | Q37405640 | ||
| New diagnostic and treatment approaches in non-alcoholic fatty liver disease (NAFLD). | Q37437435 | ||
| From sugar to fat: How the transcription factor XBP1 regulates hepatic lipogenesis | Q37596560 | ||
| Autophagy in liver diseases. | Q37784560 | ||
| Apoptosis in nonalcoholic fatty liver disease: diagnostic and therapeutic implications | Q37863133 | ||
| Role of obesity and lipotoxicity in the development of nonalcoholic steatohepatitis: pathophysiology and clinical implications | Q37983300 | ||
| Endoplasmic reticulum stress in nonalcoholic fatty liver disease | Q38027194 | ||
| Lipid-induced endoplasmic reticulum stress in liver cells results in two distinct outcomes: adaptation with enhanced insulin signaling or insulin resistance | Q39388424 | ||
| Activation and dysregulation of the unfolded protein response in nonalcoholic fatty liver disease | Q44934521 | ||
| Lipotoxicity in NASH. | Q44967579 | ||
| P4510 | describes a project that uses | ImageJ | Q1659584 |
| P433 | issue | 1 | |
| P921 | main subject | endoplasmic reticulum | Q79927 |
| metabolic dysfunction–associated steatotic liver disease | Q1546498 | ||
| fatty liver disease | Q6058862 | ||
| P304 | page(s) | 26-35 | |
| P577 | publication date | 2013-10-04 | |
| P1433 | published in | Toxicological Sciences | Q2446966 |
| P1476 | title | The adaptive endoplasmic reticulum stress response to lipotoxicity in progressive human nonalcoholic fatty liver disease | |
| P478 | volume | 137 |
| Q58697388 | A nonalcoholic fatty liver disease model in human induced pluripotent stem cell-derived hepatocytes, created by endoplasmic reticulum stress-induced steatosis |
| Q88541514 | Alcohol Metabolism in the Progression of Human Nonalcoholic Steatohepatitis |
| Q41641615 | Alcoholic steatohepatitis (ASH) causes more UPR-ER stress than non-alcoholic steatohepatitis (NASH). |
| Q35120968 | Biomarkers of NAFLD progression: a lipidomics approach to an epidemic |
| Q38577570 | Caring for children with NAFLD and navigating their care into adulthood |
| Q89558686 | Cellular Interactions in the Human Fatty Liver |
| Q34200914 | Decreasing mitochondrial fission alleviates hepatic steatosis in a murine model of nonalcoholic fatty liver disease |
| Q41115099 | Development of gene polymorphisms in meditators of nonalcoholic fatty liver disease |
| Q50420689 | Developmental origins of non-alcoholic fatty liver disease as a risk factor for exaggerated metabolic and cardiovascular-renal disease. |
| Q42362670 | Dysregulated expression of proteins associated with ER stress, autophagy and apoptosis in tissues from nonalcoholic fatty liver disease |
| Q38303313 | Early to Phase II drugs currently under investigation for the treatment of liver fibrosis |
| Q97522970 | Endoplasmic reticulum stress and liver diseases |
| Q27027733 | Endoplasmic reticulum stress in hepatic steatosis and inflammatory bowel diseases |
| Q51664532 | Genomics of human fatty liver disease reveal mechanistically linked lipid droplet-associated gene regulations in bland steatosis and nonalcoholic steatohepatitis. |
| Q26745984 | Hepatitis C Virus Infection Induces Autophagy as a Prosurvival Mechanism to Alleviate Hepatic ER-Stress Response |
| Q36382065 | Hepatocyte X-box binding protein 1 deficiency increases liver injury in mice fed a high-fat/sugar diet |
| Q36244747 | IL-1β-induced modulation of gene expression profile in human dermal fibroblasts: the effects of Thai herbal Sahatsatara formula, piperine and gallic acid possessing antioxidant properties |
| Q64999429 | IRE1α prevents hepatic steatosis by processing and promoting the degradation of select microRNAs. |
| Q38365029 | Immunoregulation by lipids during the development of non-alcoholic steatohepatitis |
| Q37710429 | Impact of high cholesterol and endoplasmic reticulum stress on metabolic diseases: An updated mini-review |
| Q37726154 | Impaired autophagic flux is associated with increased endoplasmic reticulum stress during the development of NAFLD. |
| Q92861341 | Inflammation and fibrosis in chronic liver diseases including non-alcoholic fatty liver disease and hepatitis C |
| Q38538187 | Interactions of Hepatitis B Virus Infection with Nonalcoholic Fatty Liver Disease: Possible Mechanisms and Clinical Impact |
| Q38759104 | Lipotoxicity pathways intersect in hepatocytes: Endoplasmic reticulum stress, c-Jun N-terminal kinase-1, and death receptors |
| Q36193081 | Loss of ULK1 increases RPS6KB1-NCOR1 repression of NR1H/LXR-mediated Scd1 transcription and augments lipotoxicity in hepatic cells |
| Q47413881 | Mitogen-Activated Protein Kinase Regulation in Hepatic Metabolism |
| Q33755566 | Molecular mechanisms and new treatment strategies for non-alcoholic steatohepatitis (NASH) |
| Q37062751 | Molecular mechanisms of lipotoxicity and glucotoxicity in nonalcoholic fatty liver disease |
| Q30375036 | Mouse models of diet-induced nonalcoholic steatohepatitis reproduce the heterogeneity of the human disease. |
| Q90143394 | Novel Role of Macrophage Migration Inhibitory Factor in Upstream Control of the Unfolded Protein Response After Ethanol Feeding in Mice |
| Q28071596 | Pathogenesis of Nonalcoholic Steatohepatitis: Interactions between Liver Parenchymal and Nonparenchymal Cells |
| Q36329720 | Polyphenol-Rich Fraction of Ecklonia cava Improves Nonalcoholic Fatty Liver Disease in High Fat Diet-Fed Mice |
| Q46577839 | Punicalagin attenuates palmitate-induced lipotoxicity in HepG2 cells by activating the Keap1-Nrf2 antioxidant defense system |
| Q56979449 | Role of X-Box Binding Protein-1 in Fructose-Induced Lipogenesis in HepG2 Cells |
| Q50977546 | The constitutive lipid droplet protein PLIN2 regulates autophagy in liver. |
| Q38235454 | The role of fibroblast growth factor 21 in the pathogenesis of liver disease: a novel predictor and therapeutic target |
| Q54119547 | To die or not to die: death signaling in nonalcoholic fatty liver disease. |
| Q36298151 | Undernourishment in utero Primes Hepatic Steatosis in Adult Mice Offspring on an Obesogenic Diet; Involvement of Endoplasmic Reticulum Stress |
| Q38793946 | Undernourishment in utero and hepatic steatosis in later life: A potential issue in Japanese people |
Search more.